# GPT-5.2 Review

**Role:** External referee review
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T18:28:11.267197
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 20049 in / 4309 out
**Response SHA256:** cdf8680a75c844c3

---

## Summary

The paper studies whether Brexit affected French housing prices more in départements with stronger pre-existing UK links, measured by Facebook Social Connectedness Index (SCI, measured 2021) and—preferably—UK-born resident stocks from the 2016 French census (reference date Jan 1, 2016). The main empirical approaches are: (i) a continuous-treatment DiD at département×quarter (2014–2023), (ii) a “residualized exposure” design purging UK SCI of “cosmopolitan” correlates, and (iii) a triple-difference exploiting houses vs apartments with département×quarter fixed effects. The paper adds extensive inference diagnostics (cluster bootstrap, permutation) and several placebo exercises (Germany at GADM2; BE/NL/IT/ES at GADM1).

The topic is interesting and the paper is unusually transparent about threats. However, as written, the central causal claim “Brexit” → differential French housing effects is not publication-ready for a top journal: the timing evidence is weak (and often inconsistent with an immediate post-2016 shock), the baseline DiD is undermined by pre-trends and by the sensitivity to département-specific trends, and the triple-difference that most credibly addresses confounding is (a) imprecise at département level, (b) seems to “turn on” post-2020 (Table 3), and (c) yields significant coefficients for several placebo countries in individual specifications (Table 9), raising concerns that the house–apartment differential is itself correlated with generic international exposure and/or region-level measurement artifacts. The commune-level triple-diff improves precision but does not by itself solve identification because treatment variation still occurs only across 96 clusters.

Below I focus on identification, inference validity, and what would be required to make the causal interpretation credible.

---

## 1. Identification and empirical design (critical)

### 1.1 Baseline continuous-treatment DiD: credibility is limited
- **Core identification assumption (parallel trends) is not satisfied cleanly.** The event studies report joint pre-trend tests with **p = 0.038 (SCI)** and **p = 0.048 (stock)** (Section 5.4; Figure 1 notes). These are not “borderline reassuring” in an AER/QJE sense; they indicate detectable pre-trend differences under the model the paper relies on.
- **Sensitivity to unit-specific trends is severe.** The stock×post coefficient goes from **0.0106*** (Table 1 col 2) to **-0.0005 (ns)** when adding département linear trends (Table 1 col 6; Table 8 col 6). This is not a minor robustness issue; it suggests the baseline DiD effect is largely low-frequency differential trending rather than a discrete break at Brexit.

**Implication:** As currently framed, the baseline DiD does not credibly identify a Brexit-caused effect; at best it documents a post-2016 divergence correlated with UK-linked locations, potentially reflecting gradual sorting/amenity trends or pandemic-era dynamics.

### 1.2 SCI measured post-treatment: still a concern, even if not “main”
The paper correctly flags SCI measured in 2021 as post-treatment contaminated (Intro; Section 3.2). But the paper continues to rely heavily on SCI-based triple differences and event studies. This is acceptable only if:
- the SCI is treated explicitly as a *proxy* for pre-existing links, and
- results are shown to be robust when using only the pre-determined stock (or an imputed “pre-Brexit SCI”) rather than 2021 SCI.

Right now, the stock-based triple-diff at département level is near-zero (Table 2 col 2), while SCI-based triple-diff is positive (Table 2 col 1). That divergence could itself be a symptom of post-treatment contamination of SCI rather than “more variation”.

### 1.3 Residualized exposure: not a valid causal design; interpretation needs tightening
Residualizing UK SCI on baseline controls (Section 3.2; Table 1 col 3) is informative descriptively, but:
- It is **not** a credible identification strategy for a causal “UK-specific” channel because residualization can remove real signal and can induce “bad control” style issues if controls are themselves affected by pre-trends correlated with treatment.
- The conclusion “one-fifth of UK SCI variation is cosmopolitan” based on an R² from a projection is fine as description, but the inference “raw SCI substantially confounded” is stronger than the method supports.

### 1.4 Triple-difference (houses vs apartments): promising, but key assumptions need stronger defense and evidence
Equation (2) (Section 3.3) is the paper’s best design because **département×quarter FE** absorb all common-to-type local shocks. But it introduces a different identifying assumption:

> Absent UK-specific demand, the *house–apartment price gap* would evolve similarly across high- and low-UK-exposure départements.

You provide one validation by event-studying the gap and obtaining **p = 0.240** pre-trend test for stock (Section 5.5; Figure 3). That helps.

However, several issues remain:

1. **The triple-diff effect does not appear in the pre-2020 period.** Table 3 shows essentially zero coefficients pre-2020 for both SCI and stock. This is a major challenge for attributing the effect to the 2016 referendum (or even the 2016–2019 period). The paper acknowledges this (Discussion), but the identification narrative still centers on Brexit timing.

2. **Placebo countries load on the triple-diff in individual regressions.** In Table 9, Belgium/Italy/Spain show significant triple-diff coefficients. The paper attributes this to GADM1 coarseness and collinearity, but this is not fully persuasive:
   - Coarser measurement typically attenuates coefficients; it does not obviously create spurious *type-differential* effects unless there is systematic correlation between region-level exposure and within-département type dynamics.
   - The fact that **multiple** countries “work” in triple-diff suggests the house–apartment gap may systematically widen more in internationally connected places (or in certain regions), independent of Brexit/UK.

3. **German placebo being null is supportive but insufficient.** The German null in triple-diff (Table 2 col 4) is a good sign, but not definitive given the multi-country pattern and the post-2020 timing.

4. **Exogeneity of “houses vs apartments” composition is not guaranteed.** The DVF median price per m² can change because the transacted mix changes within type (quality, location within département, size distribution). The triple-diff reduces some composition concerns but does not eliminate within-type composition changes that may differ across high-exposure areas (e.g., second-home renovation booms, rural gentrification, pandemic remote-work migration).

**Bottom line:** The triple-diff is the right direction, but you need stronger evidence that (i) the estimated post-2016 change is actually tied to Brexit-related timing/mechanisms rather than pandemic-era rural housing revaluation, and (ii) the country-placebo results are not indicating a broader “international exposure × post-2016 house boom” phenomenon.

### 1.5 Treatment timing and “Brexit” definition
You define Post as 2016-Q3 onward (Section 3.1). But Brexit is not a single shock: referendum (2016), Article 50 (2017), exit (2020), end of transition (2021). The paper’s own results suggest effects might accrue later (especially post-2020).

This creates a coherence problem: the model is anchored on 2016-Q3, but the strongest triple-diff evidence seems later. The paper needs either:
- a design targeting the referendum-window specifically (2016–2018) with compelling event-time dynamics, **or**
- a reframing away from “Brexit referendum shock” toward “Brexit era / sterling regime change / migration-policy uncertainty regime,” with corresponding empirical timing (multiple post indicators or continuous sterling index with credible exclusion restrictions).

---

## 2. Inference and statistical validity (critical)

### 2.1 Standard errors and clustering
- Main tables report clustered SEs at département level, which is appropriate given treatment varies at département level.
- With 96 clusters, asymptotics are usually acceptable; your **pairs cluster bootstrap** check (Section 6.1; Table 7) is helpful.

**But** two inference concerns remain:

1. **Commune-level regressions with 96 clusters** (Table 10): you correctly cluster at département, but the paper at times suggests the much larger N “yields more precise estimates” (Abstract; Section 6.4). Precision can increase mechanically in CRVE due to more within-cluster observations, but with only 96 clusters the effective information is still limited; you should lean more heavily on **wild cluster bootstrap (WCR)** p-values and report them in the tables (not only “in the text”), especially because the commune-level results are a key “fix” for imprecision.

2. **Permutation inference** (Section 6.5) permuting stock across départements is fine as a robustness check, but validity depends on exchangeability (which is questionable if exposure correlates with spatial/structural features). It should be framed as a heuristic diagnostic, not as definitive randomization inference.

### 2.2 Multiple testing / specification search risk
Given:
- multiple exposure measures (SCI, stock, residualized),
- multiple samples (full, pre-2020, 2014–2018),
- multiple outcomes (levels; gap; triple-diff),
- multiple placebos (DE, CH earlier; plus BE/NL/IT/ES),
the paper is vulnerable to “selective emphasis” even if unintentional.

Top journals increasingly expect transparency adjustments (e.g., pre-registration is not required, but some accounting helps). Consider controlling the family-wise error rate for the placebo battery or using false discovery rate, at least for the set of country-placebo triple-diff tests.

---

## 3. Robustness and alternative explanations

### 3.1 COVID/remote-work rural boom is a first-order alternative explanation
You discuss it candidly (Background; Discussion), but it still threatens the central claim because:
- triple-diff is null pre-2020 (Table 3),
- full-sample triple-diff positive (Table 2; Table 10),
- the UK-linked départements plausibly overlap with high-amenity rural/second-home areas that boomed during COVID, independent of UK demand.

You partly address via a 2014–2018 restriction for the baseline DiD (Table 8 col 4), but not with an equivalently strong triple-diff restriction that isolates 2016–2019 dynamics (you do pre-2020, but that includes 2016–2019; still null). This is a serious problem for a Brexit interpretation.

### 3.2 Mechanism: exchange rate interaction is not clean and placebo fails
The sterling weakness interaction (Table 11) has the “right” sign for UK exposure, but the **German placebo is also significant and larger**. This undermines the exchange-rate mechanism as interpreted. As written, the mechanism section ends up reinforcing confounding.

If the key mechanism cannot be separated from generic macro conditions, the paper should scale back mechanism claims and present sterling results as suggestive/descriptive.

### 3.3 Placebo battery interpretation needs stronger structure
The GADM1 vs GADM2 mismatch is a major limitation you acknowledge (Discussion; Limitations), but since the placebo battery is a central “diagnostic toolkit” contribution, the paper should either:
- obtain comparable-resolution SCI for all countries (preferred), or
- redesign the placebo strategy so comparisons are apples-to-apples (e.g., aggregate UK/DE SCI to GADM1 too and compare within the same resolution; then show robustness to resolution choice).

Right now, the fact that BE/IT/ES are significant in triple-diff but become insignificant in the horse race could reflect multicollinearity rather than true “diagnosis”; horse races with highly correlated exposures often yield unstable coefficients and are not a strong discriminator.

---

## 4. Contribution and literature positioning

### 4.1 Contribution
- Methodologically, the paper’s core message—SCI exposure designs can be confounded by cosmopolitan trends and benefit from placebo batteries and within-unit heterogeneity—is valuable.
- Substantively, cross-border housing spillovers of major political events is also interesting.

But to reach a top general-interest bar, the *economic* contribution needs a clearer, credibly identified causal effect with interpretable magnitude and timing. Currently the paper’s own diagnostics suggest the cleanest statement is closer to:

> “UK-connected places experienced different post-2016 house-vs-apartment dynamics, especially after 2020,”

which is less clearly “Brexit” and more “internationally connected amenity/rural housing dynamics in the Brexit era”.

### 4.2 Missing / recommended citations
You cite key shift-share and DiD sensitivity pieces. Consider also:
- **de Chaisemartin & D’Haultfoeuille (2020, 2022)** on TWFE DiD with heterogeneous effects—while you argue staggered timing is not central, readers may still expect engagement on TWFE pitfalls with continuous treatments and dynamic effects.
- **Imai, Kim, Wang (2023)** or related work on event-study pre-trend testing and power (depending on your approach).
- For foreign demand/housing: **Favilukis, Van Nieuwerburgh, and others** on international capital and housing, and empirical work on second-home markets if relevant to France.
- For SCI design and confounding: any newer critiques/validations post-2018 (you have some).

---

## 5. Results interpretation and claim calibration

The paper is unusually candid, but several claims still feel ahead of the evidence:

- **“Brexit represented an exogenous shock transmitted through pre-existing networks” (Intro)**: the shock is exogenous, but transmission through networks is not directly shown (no UK-buyer data; mechanisms are indirect and exchange-rate channel fails placebo).
- **Causal language around “effect of Brexit”** should be moderated unless timing evidence is strengthened. Your own Discussion concedes uncertainty distinguishing Brexit from post-2016 regime changes plus COVID.
- **Triple-diff as “cleanest evidence”**: it is cleaner on confounding, but the multi-country placebo issues and the post-2020 onset mean it is not yet clean evidence of Brexit specifically.

Effect sizes: a coefficient like 0.0106 on log stock×post is interpretable but you should translate into economically meaningful contrasts (e.g., Dordogne vs median département) and show implied euro/m² changes, with uncertainty. Make sure these are not overstated given the trend sensitivity.

---

## 6. Actionable revision requests (prioritized)

### 1) Must-fix issues before acceptance

1. **Clarify and (likely) reframe the causal estimand away from “Brexit referendum caused X” unless timing evidence supports it.**  
   - *Why:* Triple-diff is null pre-2020; baseline DiD fails pre-trends and is trend-sensitive.  
   - *Fix:* Either (a) focus on a clearly justified post period tied to a specific Brexit milestone (2016 vote; 2020 exit; 2021 transition end) and show event-time dynamics consistent with that milestone, or (b) explicitly reframe to “Brexit era / UK-linked exposure interacted with post-2016 regime change,” with appropriately tempered causal language throughout.

2. **Resolve the multi-country placebo ambiguity with an apples-to-apples placebo design.**  
   - *Why:* Significant BE/IT/ES triple-diff coefficients suggest the design may capture generic international exposure effects on the house–apartment gap. Horse races are not decisive under multicollinearity.  
   - *Fix options:*  
     - Obtain GADM2 SCI for all placebo countries and redo Table 9; **or**  
     - Aggregate UK and DE exposure to GADM1 and redo all countries at GADM1; then show results are consistent across resolutions; **or**  
     - Implement a structured placebo design using “synthetic exposure” (randomly reweight UK regions) to generate a null distribution under comparable measurement.

3. **Strengthen the triple-difference validity checks beyond a single pre-trend F-test.**  
   - *Why:* The identifying assumption is about *gap dynamics*; you need richer evidence it is stable and not driven by differential composition/quality within types.  
   - *Concrete fixes:*  
     - Show event studies for the **gap** separately for pre-2016 and for multiple post windows (2016–2019; 2020–2023).  
     - Add controls for within-type composition (e.g., median size, rooms, land area if available) at département×type×quarter and show results are robust.  
     - Show robustness using alternative price measures: repeat-sales or hedonic indices (even if on a subsample) to reduce composition bias.

4. **Make inference for commune-level results fully rigorous and prominent.**  
   - *Why:* Commune-level precision gains with only 96 clusters can be misleading without WCR bootstrap reporting.  
   - *Fix:* Report wild cluster bootstrap p-values/CI in Table 10 (and key other tables), and describe the bootstrap procedure (weights, null imposed, repetitions).

### 2) High-value improvements

5. **Model treatment timing more flexibly (multiple post indicators / continuous event time).**  
   - *Why:* Brexit is multi-stage; effects may be gradual.  
   - *Fix:* Estimate dynamic effects allowing breaks at 2016Q3, 2017Q2, 2020Q1, 2021Q1; or use spline/event-time with clear interpretation and pre-specification.

6. **Provide an explicit mapping from UK exposure to plausible demand channels.**  
   - *Why:* Without buyer nationality, you need triangulation.  
   - *Fix:* Bring in auxiliary evidence: British population changes by département (post-2016), UK–France migration/registrations, notarial statistics on foreign buyers by region if any exist, or Google Trends/search data for “acheter maison Dordogne” from UK IPs (even suggestive).

7. **Quantify economic magnitude with representative contrasts and uncertainty.**  
   - *Why:* General-interest readers need scale.  
   - *Fix:* Translate estimates into predicted price changes for 25th vs 75th percentile exposure départements; report implied €/m² and aggregate wealth effects with CIs.

### 3) Optional polish (substance, not prose)

8. **Tighten the role of “residualized exposure” as descriptive only.**  
   - *Fix:* Move it to a diagnostics section; avoid implying it identifies causal UK-specific variation.

9. **Multiple-testing adjustments for placebo battery.**  
   - *Fix:* Report FDR-adjusted q-values for individual placebo tests; emphasize joint tests.

---

## 7. Overall assessment

### Key strengths
- Excellent transparency about identification threats; the German placebo diagnostic is a strong and honest feature.
- The triple-difference with département×quarter FE is a thoughtful attempt to address time-varying local confounds.
- Serious attention to inference (cluster bootstrap, permutation, leave-one-out), rare in this literature.
- Data sources are high-quality and replication materials are promised.

### Critical weaknesses
- The paper does not yet credibly isolate **Brexit-specific** causal effects: baseline DiD shows pre-trends and collapses with trends; triple-diff effects appear absent pre-2020.
- Multi-country placebo results raise the possibility that the triple-diff is capturing broader patterns in house–apartment dynamics among internationally connected places, not UK/Brexit-specific effects.
- Mechanism evidence (sterling) fails the placebo test, weakening the “UK demand channel” interpretation.

### Publishability after revision
With major redesign/clarification of the estimand and a stronger, apples-to-apples placebo strategy (plus stronger gap/hedonic robustness), the paper could become publishable—likely as a methodological contribution about SCI exposure designs with an application to Brexit-era housing. In its current form, the causal claims and timing do not meet a top general-interest identification bar.

DECISION: MAJOR REVISION